GlassScriptPhysician profile
Sabrina Benefield Castle
NPI 1023085925
$1,585.57
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $408 · 2020: $361 · 2021: $481 · 2022: $257 · 2023: $64.10 · 2024: $14.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $389.88 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Lupin INC. | $360.65 | 2019-2021 | |
| Avanos Medical | $234.17 | 2020-2021 | |
| Pfizer INC. | $85.97 | 2019-2022 | |
| Evofem Biosciences, INC. | $73.79 | 2020-2023 | Phexxi |
| Duchesnay USA Incorporated | $65.84 | 2019 | |
| Myovant Sciences INC. | $57.67 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $36.98 | 2019 | |
| Allergan, INC. | $31.15 | 2020 | |
| Exeltis, USA INC. | $30.41 | 2022 | |
| Mayne Pharma Commercial LLC | $29.72 | 2022 | |
| Therapeuticsmd, INC. | $27.07 | 2021-2022 | |
| Avion Pharmaceuticals | $26.79 | 2021 | |
| Merck Sharp & Dohme LLC | $22.17 | 2020 | |
| Millicent US INC | $18.74 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $18.64 | 2019 | |
| Shield Therapeutics INC | $16.60 | 2022 | |
| Sage Therapeutics, LLC | $16.56 | 2019 | |
| Sumitomo Pharma America, INC. | $15.77 | 2023 | Myfembree |
| Organon LLC | $14.49 | 2024 | |
| Radius Health, INC. | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sabrina Castle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.